Compounds of Formula I: (where variables R1, R2, R3, R7, G, J, Q, T, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache, and pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. ##STR00001##

 
Web www.patentalert.com

< Method of predicting the onset of sepsis in SIRS-positive individuals using mass spectrometry

> Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators

> Diagnostic markers of stroke and cerebral injury and methods of use thereof

~ 00566